196 related articles for article (PubMed ID: 30921263)
21. PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia.
St John LS; Wan L; He H; Garber HR; Clise-Dwyer K; Alatrash G; Rezvani K; Shpall EJ; Bollard CM; Ma Q; Molldrem JJ
Cytotherapy; 2016 Aug; 18(8):995-1001. PubMed ID: 27378343
[TBL] [Abstract][Full Text] [Related]
22. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.
Huang GP; Pan ZJ; Jia BB; Zheng Q; Xie CG; Gu JH; McNiece IK; Wang JF
Cell Transplant; 2007; 16(6):579-85. PubMed ID: 17912949
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo expansion of human umbilical cord blood does not lead to co-expansion of contaminating maternal mononuclear cells.
Fietz T; Hilgenfeld E; Berdel WE; Hopp H; Wenzel U; Dohle W; Thiel E; Knauf WU
Bone Marrow Transplant; 1997 Dec; 20(12):1019-26. PubMed ID: 9466273
[TBL] [Abstract][Full Text] [Related]
24. Third-party regulatory T cells prevent murine acute graft-versus-host disease.
Lim JY; Im KI; Song Y; Kim N; Nam YS; Jeon YW; Cho SG
Korean J Intern Med; 2018 Sep; 33(5):980-989. PubMed ID: 29050459
[TBL] [Abstract][Full Text] [Related]
25. Initial depletion of regulatory T cells: the missing solution to preserve the immune functions of T lymphocytes designed for cell therapy.
Mesel-Lemoine M; Cherai M; Le Gouvello S; Guillot M; Leclercq V; Klatzmann D; Thomas-Vaslin V; Lemoine FM
Blood; 2006 Jan; 107(1):381-8. PubMed ID: 16160005
[TBL] [Abstract][Full Text] [Related]
26. [IMMUNOGENICITY OF HUMAN UMBILICAL CORD BLOOD DERIVED MESENCHYMAL STEM CELLS AFTER OSTEOGENIC INDUCTION].
Yang D; Lin H; Liu G
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jun; 28(6):752-7. PubMed ID: 26455231
[TBL] [Abstract][Full Text] [Related]
27. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
Xia G; He J; Zhang Z; Leventhal JR
Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
[TBL] [Abstract][Full Text] [Related]
28. Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood.
Condiotti R; Zakai YB; Barak V; Nagler A
Exp Hematol; 2001 Jan; 29(1):104-13. PubMed ID: 11164111
[TBL] [Abstract][Full Text] [Related]
29. Importance of B cells to development of regulatory T cells and prolongation of tissue allograft survival in recipients receiving autologous bone marrow transplantation.
Gorczynski RM; Farrokhi K; Gorczynski C; Sadozai H; Zhu F; Khatri I
Immunology; 2018 Jul; 154(3):465-475. PubMed ID: 29338084
[TBL] [Abstract][Full Text] [Related]
30. Expanded umbilical cord blood T cells used as donor lymphocyte infusions after umbilical cord blood transplantation.
Berglund S; Gertow J; Uhlin M; Mattsson J
Cytotherapy; 2014 Nov; 16(11):1528-1536. PubMed ID: 25231890
[TBL] [Abstract][Full Text] [Related]
31. [Umbilical cord blood as a source of stem cells].
Bojanić I; Golubić Cepulić B
Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood.
Wei YM; Cao Q; Zhou HY; Xia R; Lan JC; Meng FY; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1076-81. PubMed ID: 16403284
[TBL] [Abstract][Full Text] [Related]
33. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.
Bulatović Ćalasan M; Vastert SJ; Scholman RC; Verweij F; Klein M; Wulffraat NM; Prakken BJ; van Wijk F
Rheumatology (Oxford); 2015 Sep; 54(9):1724-34. PubMed ID: 25877908
[TBL] [Abstract][Full Text] [Related]
34. Ex vivo expansion and Th1/Tc1 maturation of umbilical cord blood T cells by CD3/CD28 costimulation.
Mazur MA; Davis CC; Szabolcs P
Biol Blood Marrow Transplant; 2008 Oct; 14(10):1190-1196. PubMed ID: 18804050
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of intracellular galectin-1-expressing lymphocytes in umbilical cord blood in comparison with adult peripheral blood.
Kollár S; Sándor N; Molvarec A; Stenczer B; Rigó J; Tulassay T; Vásárhelyi B; Toldi G
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1608-13. PubMed ID: 22609846
[TBL] [Abstract][Full Text] [Related]
36. In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation.
Tahvildari M; Omoto M; Chen Y; Emami-Naeini P; Inomata T; Dohlman TH; Kaye AE; Chauhan SK; Dana R
Transplantation; 2016 Mar; 100(3):525-32. PubMed ID: 26881788
[TBL] [Abstract][Full Text] [Related]
37. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
[TBL] [Abstract][Full Text] [Related]
38. Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.
Aricha R; Reuveni D; Fuchs S; Souroujon MC
J Autoimmun; 2016 Feb; 67():57-64. PubMed ID: 26489998
[TBL] [Abstract][Full Text] [Related]
39. Expansion of regulatory T cells from umbilical cord blood and adult peripheral blood CD4(+)CD25 (+) T cells.
Lin SJ; Lu CH; Yan DC; Lee PT; Hsiao HS; Kuo ML
Immunol Res; 2014 Oct; 60(1):105-11. PubMed ID: 24515612
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic cord blood regulatory T cells can resolve lung inflammation.
Lyu MA; Huang M; Zeng K; Li L; Khoury JD; Nishimoto M; Ma H; Sadeghi T; Mukherjee S; Slutsky AS; Flowers CR; Parmar S
Cytotherapy; 2023 Mar; 25(3):245-253. PubMed ID: 36437190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
